FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory

Journal of Immunology

Volumn 164, Issue 11, 2000, Pages 5761-5770

  Pinschewer, Daniel D ^a   Ochsenbein, Adrian F ^a   Odermatt, Bernhard ^b   Brinkmann, Volker ^c   Hengartner, Hans ^a   Zinkernagel, Rolf M ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FINGOLIMOD; HOMING RECEPTOR; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CYTOTOXIC T LYMPHOCYTE; DIABETES MELLITUS; DRUG MECHANISM; GRAFT SURVIVAL; IMMUNOMODULATION; IMMUNOPATHOLOGY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOCYTOPENIA; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VESICULAR STOMATITIS VIRUS; VIRUS MENINGITIS; VIRUS REPLICATION;

EID: 0034120178     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.11.5761     Document Type: Article

References (41)

1. Kluepfel, D., J. Bagli, H. Baker, M. P. Charest, and A. Kudelski. 1972. Myriocin, a new antifungal antibiotic from Myriococcum albomyces. J. Antibiot. 25:109.
2. Fujita, T., K. Inoue, S. Yamamoto, T. Ikumoto, S. Sasaki, R. Toyama, K. Chiba, Y. Hoshino, and T. Okumoto. 1994. Fungal metabolites. II. A potent immunosuppressive activity found in Isaria sinclairii metabolite. J. Antibiot. 47:208.
3. Suzuki, S., S. Enosawa, T. Kakefuda, T. Shinomiya, M. Amari, S. Naoe, Y. Hoshino, and K. Chiba. 1996. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 61:200.
4. Suzuki, S., S. Enosawa, T. Kakefuda, H. Amemiya, Y. Hoshino, and K. Chiba. 1996. Long-term graft acceptance in allografted rats and dogs by treatment with a novel immunosuppressant, FTY720. Transplant. Proc. 28:1375.
5. Wang, M. E., N. Tejpal, X. Qu, J. Yu, M. Okamoto, S. M. Stepkowski, and B. D. Kahan. 1998. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Transplantation 65:899.
6. Stepkowski, S. M., M. Wang, X. Qu, J. Yu, M. Okamoto, N. Tejpal, and B. D. Kahan. 1998. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival. Transplant. Proc. 30:2214.
7. Shinomiya, T., X. K. Li, H. Amemiya, and S. Suzuki. 1997. An immunosuppressive agent, FTY720, increases intracellular concentration of calcium ion and induces apoptosis in HL-60. Immunology 91:594.
8. Suzuki, S., X. K. Li, S. Enosawa, and T. Shinomiya. 1996. A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes. Immunology 89:518.
9. Chiba, K., Y. Yanagawa, Y. Masubuchi, H. Kataoka, T. Kawaguchi, M. Ohtsuki, and Y. Hoshino. 1998. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 160:5037.
10. Yanagawa, Y., K. Sugahara, H. Kataoka, T. Kawaguchi, Y. Masubuchi, and K. Chiba. 1998. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J. Immunol. 160:5493.
11. Zinkernagel, R. M., and P. C. Doherty. 1979. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 27:51.
12. Buchmeier, M. J., R. M. Welsh, F. J. Dutko, and M. B. A. Oldstone. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:275.
13. Lehmann-Grube, F. 1971. Lymphocytic choriomeningitis virus. Virol. Monogr. 10:1.
14. Hotchin, J. 1962. The biology of lymphocytic choriomeningitis infection: virus induced immune disease. Cold Spring Harbor Symp. Quant. Biol. 27:479.
15. Steinhoff, U., U. Müller, A. Schertler, H. Hengartner, M. Aguet, and R. M. Zinkernagel. 1995. Antiviral protection by vesicular stomatitis virus-specific antibodies in α/β interferon receptor-deficient mice. J. Virol. 69:2153.
16. Bachmann, M. F., and R. M. Zinkernagel. 1997. Neutralizing antiviral B cell responses. Annu. Rev. Immunol. 15:235-70:235.
17. Battegay, M., S. Cooper, A. Althage, J. Baenziger, H. Hengartner, and R. M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24-or 96-well plates. J. Virol. Methods 33:191.
18. Bachmann, M. F., H. Hengartner, and R. M. Zinkernagel. 1994. Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody induction. Med. Microbiol. Immunol. Berlin 183:315.
19. Oehen, S., K. Brduscha-Riem, A. Oxenius, and B. Odermatt. 1997. A simple method for evaluating the rejection of grafted spleen cells by flow cytometry and tracing adoptively transferred cells by light microscopy. J. Immunol. Methods 207:33.
20. Kündig, T. M., A. Althage, H. Hengartner, and R. M. Zinkernagel. 1992. Skin test to assess virus-specific cytotoxic T-cell activity. Proc. Natl. Acad. Sci. USA 89: 7757.
21. + T lymphocytes. Proc. Natl. Acad. Sci. USA 86:3291.
22. Zinkernagel, R. M., T. Leist, H. Hengartner, and A. Althage. 1985. Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D. J. Exp. Med. 162:2125.
23. Bachmann, M. F., B. Odermatt, H. Hengartner, and R. M. Zinkernagel. 1996. Induction of long-lived germinal centers associated with persisting antigen after viral infection. J. Exp. Med. 183:2259.
24. Battegay, M., D. Moskophidis, H. Waldner, M. A. Brundler, W.-P. Fung-Leung, T. W. Mak, H. Hengartner, and R. M. Zinkernagel. 1993. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. J. Immunol. 151:5408.
25. Ohashi, P. S., S. Oehen, K. Buerki, H. Pircher, C. T. Ohashi, B. Odermatt, B. Malissen, R. M. Zinkernagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305.
26. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548.
27. Huegin, A. W., A. Cerny, H. Hengartner, and R. M. Zinkernagel. 1985. Suppression by cyclosporin A of murine T-cell-mediated immunity against viruses in vivo and in vitro. Cell. Immunol. 90:464.
28. Jolivet, J., K. H. Cowan, G. A. Curt, N. J. Clendeninn, and B. A. Chabner. 1983. The pharmacology and clinical use of methotrexate. N. Engl. J. Med. 309:1094.
29. Kahan, B. D. 1989. Cyclosporine. N. Engl. J. Med. 321:1725.
30. Enosawa, S., S. Suzuki, T. Kakefuda, X. K. Li, and H. Amemiya. 1996. Induction of selective cell death targeting on mature T-lymphocytes in rats by a novel immunosuppressant, FTY720. Immunopharmacology 34:171.
31. Mackay, C. R. 1991. T cell memory: the connection between function, phenotype and migration pathways. Immunol. Today 12:189.
32. + T cells during an acute virus infection. Immunity 8:167.
33. + memory T cells in virus-infected host. J. Exp. Med. 183:1367.
34. Kagi, D., B. Odermatt, P. S. Ohashi, R. M. Zinkernagel, and H. Hengartner. 1996. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med. 183:2143.
35. Borrow, P., C. F. Evans, and M. B. Oldstone. 1995. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69:1059.
36. Vieira, P., and K. Rajewsky. 1988. The half-lives of serum immunoglobulins in adult mice. Eur. J. Immunol. 18:313.
37. Charan, S., and R. M. Zinkernagel. 1986. Antibody mediated suppression of secondary IgM response in nude mice against vesicular stomatitis virus. J. Immunol. 136:3057.
38. Roost, H.-P., S. Charan, and R. M. Zinkernagel. 1990. Analysis of the kinetics of antiviral memory T help in vivo: characterization of short-lived cross-reactive T help. Eur. J. Immunol. 20:2547.
39. Wagner, R. R., A.H. Levy, R. M. Synder, G. A. Ratcliff, and D. F. Hyatt. 1963. Biologic properties of two plaque variants of vesicular stomatitis virus (Indiana serotype). J. Immunol. 91:112.
40. Oehen, S., H. Waldner, T. M. Kündig, H. Hengartner, and R. M. Zinkernagel. 1992. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J. Exp. Med. 176:1273
41. Brinkmann, V., D. Pinschewer, K. Chiba, and L. Feng. 2000. FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. Trends Pharmacol. Sci. 21:49.